±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 5980  |  »Ø¸´: 14
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

weigonghong

Ìú³æ (³õÈëÎÄ̳)

[½»Á÷] ·ÒÀ¼°Â¬´óѧÉúÎïÖÐÐÄÕÐÆ¸¹«ÅÉÁªºÏÅàÑø,¹«ÅɶÁ²©£¬·ÃÎÊѧÕߺÍÏà¹ØÑ§Éú ÒÑÓÐ11È˲ÎÓë

ÎÒ×î½üÔÚ·ÒÀ¼°Â¬´óѧ(University of Oulu)ÉúÎïÖÐÐÄ×齨ÁËÒ»¸öʵÑéÊÒ£¬Ö÷ÒªÑо¿»ùÒòת¼µ÷¿ØÍøÂçºÍ°©Ö¢£¬¸öÌå·¢ÓýµÄ»úÖÆ¡£ÏêÇéÇë¼ûÎÒµÄʵÑéÊÒÖ÷Ò³http://www.oulu.fi/biocenter/groups/wei
ÔÚ´ËÏ£ÍûÏà¹Ø×¨Òµ£¬¶ÔÎÒµÄÑо¿¸ÐÐËȤµÄ¹«ÅÉÁôѧÉú(¹«ÅɶÁ²©)»òÕß·ÃÎÊѧÕß¼ÓÈ룬¹¤×÷ÓïÑÔΪӢÓï¡£±¾ÊµÑéÊÒÒѽ¨Á¢¶à¸ö»ùÒòÇóýÄ£ÐͺÍһϵÁÐ×îеÄÏÂÒ»´ú²âÐòÏà¹ØµÄ¸ßͨÁ¿¼¼Êõ£¬ÒÔ¼°¶à¸öµÄ¹ú¼ÊÐÔºÏ×÷»ú»á£¬°üÀ¨ºÍºÕ¶ûÐÁ»ù´óѧ£¬¿¨ÂÞÁÖ˹¿¨Ò½Ñ§ÔººÍ¹þ¸¥Ò½Ñ§ÔºµÈ¡£È·±£Äܹ»¸øÄãºÜºÃµÄ¿ÆÑÐѵÁ·£¬ÓÐÐËȤÇë¸øÎÒдÐÅgonghong.wei@oulu.fi
·ÒÀ¼°Â¬´óѧ£¬È«ÇòÅÅÃûÔÚ300-400¼ä£¬ËäÈ»Ëã²»ÉÏ×îºÃ£¬µ«¾ø²»Ëã²î¡£ËýµÄµØÀíλÖñȽϿ¿±±£¬¶¬ÌìºÚ£¬µ«²»À䣨±±´óÎ÷ÑóůÁ÷£©¡£ÖÁÓÚ˵һЩÊÖÐøÎÊÌ⣬ÎÒÕâÀï»áŬÁ¦°ïæ½â¾ö¡£
²©Ê¿×¢²á»ù±¾ÒªÇóÈçÏ£¨´ó¸ÅµÄÄÚÈÝ£©
1¡¢Ó¢Óï³É¼¨ TOFEL 570PBT/88IBT£»»òAÀàIELTS 6.5 £¨Ð¡·Ö×îµÍ5.5£©£»»òÕß˶ʿѧϰ½×¶ÎΪӢÓïÊڿΡ£
2¡¢Ë¶Ê¿Ñ§Î»Ö¤¾­CDGDCתËÍ
3¡¢Ñ§Ï°¼Æ»®
4¡¢µ¼Ê¦Í¬Òâ½ÓÊÜ
±¾ÊµÑéÊÒÑо¿·¶Î§µÄÓ¢ÎĸÅÀ¨
The Biocenter Oulu is the forefront organization of biosciences and molecular medicine in the University of Oulu, Finland. The functional genomics laboratory of Dr. Gonghong Wei at the Center is inviting application for exchanging and CSC-supported PhD students, and visiting scholars.
The research group focuses on fundamental roles of the ETS family transcription factors in the cell growth control, prostate cancer and leukemia. There are nearly 30 ETS members in the human and mouse genomes, respectively. We aim to address on a genome-wide scale how the oncogenic ETS family members contribute targeting specificity in the specific cancer-type context? What mechanisms confer the unique biological roles of the ETS factors in vivo? We will apply ChIP-seq, FAIRE-seq, DNase-seq and 3C-derived methods in combination with the next-generation sequencing (NGS) technology to map ETS cistrome, epigenetic profile, open chromatin context and long-range chromatin interactome. We will also perform RNA-seq/Affymetrix chip to capture the transcriptome landscape/expression profiling after perturbation of individual ETS member. The resulting regulatory genomic data will be further applied to determining the functional genetic variants identified by genome-wide association studies. The critical ETS targets of clinical interest will be deeply validated in multiple animal models including transgenic and knockin/out mice.
Qualifications
The candidate should hold or have a to-be-achieved MSc or PhD in molecular cell biology or a related field as well as strong motivation to work in a dynamic and challenging research area of molecular medicine. The candidate should have good communication skills in English and expertise in life sciences and biomedicine. Interested candidates please email your CV, statement of research interests, and the contact information of two or three references to gonghong.wei@oulu.fi

[ Last edited by flyingskynk on 2012-5-18 at 23:21 ]
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

Å£µ¼Å£Ð£Å£×ÊÁÏ

» ±¾Ìû@֪ͨ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

imxiaoqiao

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÄãºÃÏñÊÇÈ¥ÄêÄõ½°Â¬´óѧµÄְλµÄ°É£¿ÎҼǵÃÎÒÔÚÄÄ¿´¹ý£¬ÎÒÔÚTurkuµÄBiocity£¬ÈÏʶһÏ£¬¶¥Ò»¸ö£¡£¡

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

10Â¥2012-03-22 05:37:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 15 ¸ö»Ø´ð
×£¸£¡£¡£¡£¡£¡£
2Â¥2012-03-03 09:50:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

beimi

ľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÒѾ­½»ÁË£¬Òª²»¾ÍÈ¥À­£¬×£¸£Â¥Ö÷ÕÒµ½ºÃѧÉú°¡£¡
3Â¥2012-03-03 09:55:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liuhaitao3592

ľ³æ (ÖªÃû×÷¼Ò)


¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÏÖÔÚÓеãÍíÁË£¬CSCÏÖÔÚ¶¼¿ªÊ¼ÍøÉêÁË£¬×£¸£
4Â¥2012-03-03 10:18:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 301Çóµ÷¼Á +15 121. 2026-04-04 15/750 2026-04-07 02:14 by BruceLiu320
[¿¼ÑÐ] Ò»Ö¾Ô¸ËÕÖÝ´óѧ²ÄÁϹ¤³Ì£¨085601£©×¨Ë¶ÓпÆÑо­ÀúÈýÏî¹ú½±Á½¸öʵÓÃÐÍרÀûÒ»ÏîÊ¡¼¶Á¢Ïî +11 ´ó»ðɽС»ðɽ 2026-04-05 11/550 2026-04-06 22:55 by yunlongyang
[¿¼ÑÐ] 347²ÄÁÏר˶Çóµ÷¼Á +7 zj8215216 2026-04-06 7/350 2026-04-06 21:57 by dongzh2009
[¿¼ÑÐ] µÚÒ»Ö¾Ô¸¶«ÄÏ´óѧÎïÀí313£¬ÓпÆÑоºÈü»ñ½±¾­Àú£¬Ï£ÍûÎïÀí¸´ÊÔµ÷¼Á +3 ÂíÄÚ³È 2026-04-05 3/150 2026-04-06 10:32 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +10 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-05 10/500 2026-04-06 09:35 by jp9609
[¿¼ÑÐ] 329Çóµ÷¼Á +17 miaodesi 2026-04-02 20/1000 2026-04-05 18:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 085500»úеר˶³õÊÔ288Çóµ÷¼Á +3 GZJguo666- 2026-04-05 3/150 2026-04-05 18:06 by jkddd
[¿¼ÑÐ] 085600µ÷¼Á +9 ¶«ÕÕÕÕÕÕ 2026-04-04 9/450 2026-04-05 13:44 by ujn_zhuj
[¿¼ÑÐ] µ÷¼ÁÇóÖú +10 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 13/650 2026-04-05 09:41 by sam3303
[¿¼ÑÐ] 333Çóµ÷¼Á +12 wfh030413@ 2026-04-03 13/650 2026-04-04 21:02 by jj987
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª±±µçÁ¦´óѧ£¨±±¾©£©£¬²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶265£¬Çóµ÷¼Á +11 yelck 2026-04-03 12/600 2026-04-04 19:52 by dongzh2009
[¿¼ÑÐ] 292Çóµ÷¼Á +11 2022080213 2026-04-04 13/650 2026-04-04 18:38 by macy2011
[¿¼ÑÐ] 295Çóµ÷¼Á +3 ÉÐټѽ 2026-04-03 4/200 2026-04-03 21:23 by zhq0425
[¿¼ÑÐ] 315·Ö 085602 Çóµ÷¼Á +15 26¿¼ÑÐÉϰ¶°æ26 2026-04-02 15/750 2026-04-03 12:45 by xingguangj
[¿¼ÑÐ] 08¹¤¿Æ275·ÖÇóµ÷¼Á +14 AaAa7420 2026-03-31 14/700 2026-04-03 11:13 by cocolv
[¿¼ÑÐ] 274Çóµ÷¼Á +10 Ѧ¶¨Ú̵Ļ¢¡£ 2026-04-01 10/500 2026-04-03 10:13 by tianyyysss
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +6 ´ó²öС×Ó 2026-04-02 6/300 2026-04-02 21:54 by dongzh2009
[¿¼ÑÐ] 22408 266Çóµ÷¼Á +3 masss11222 2026-04-02 3/150 2026-04-02 18:11 by ±ÊÂä½õÖÝ
[¿¼ÑÐ] 279Çóµ÷¼Á +5 ¸µÎÄÇï 2026-04-02 5/250 2026-04-02 18:10 by ±ÊÂä½õÖÝ
[¿¼ÑÐ] Ó¢Ò»ÊýÒ»×Ü·Ö334Çóµ÷¼Á +4 ³ÂÑôÀ¤ 2026-03-31 4/200 2026-03-31 14:22 by ¼Çʱ¾2026
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û